Utah at AAN

Utah at AAN

See what the Department of Neurology is doing at the American Academy of Neurology's Annual Meeting.

Learn More
Pulst Research

Research Breakthrough

A treatment breakthrough in Dr. Stefan Pulst's lab reverses signs of two degenerative brain diseases, ALS and Ataxia, in mice.

Learn More
Headache School

Headache School

Learn about migraine and headache at weekly educational and therapeutic sessions with the experts.

Learn More
Research

Research

Encompassing a wealth of research topics and studies in six operating labs, including genetics, Alzheimer's care, headache physiology, movement disorders, pediatric motor disorders, and peripheral neuropathy.

Learn More
50th Anniversary

Neurology Turns 50

The Department of Neurology celebrated its 50th anniversary in conjunction with the Western Intermountain Neurological Organization (WINO) conference in April 2016.

Learn More
Fellowships

Fellowships

Our department offers over 10 fellowships with in-depth clinical experience to train the next generation of leaders in neurological medicine.

Learn More

Department of Neurology

The Department of Neurology at the University of Utah is committed to ending neurological disease through specialized patient care, innovative research, and the education of tomorrow's physicians. Our department provides comprehensive primary and tertiary neurologic care, as well as both inpatient and outpatient neurologic consultation.

Latest News

Treatment Reverses Signs of Two Degenerative Brain Diseases, ALS and Ataxia, in Mice
Research
Apr 12, 2017

Treatment Reverses Signs of Two Degenerative Brain Diseases, ALS and Ataxia, in Mice

Clinical Neurosciences Center, , als, ataxia

Scientists report a significant step toward combatting two degenerative brain diseases that chip away at an individual’s ability to move, and think. A targeted therapy developed by scientists at University of Utah Health slows the progression of a condition in mice that mimics a rare disease called ataxia. In a parallel collaborative study, led by researchers at Stanford University, a nearly identical treatment improves the health of mice that model Amyotrophic Lateral Sclerosis (ALS), commonly called Lou Gehrig’s disease. ... Read More

Neurology

Message From Our Department Chair, Stefan Pulst, MD

Pulst

Read More

Help Progress, Give Today

You can help the Department of Neurology continue to progress with even a small contribution.

Give Today!